Fractional Support for Pharma Insight Teams
Pharma insights teams operate in a uniquely high-stakes environment. Internal stakeholders expect clear, defensible insights. Vendors vary widely in quality. Timelines are compressed. And insights leaders are often asked to challenge methodological decisions without having a senior methodologist on staff.
The result is a constant tension: insights teams are accountable for the quality of research they did not design, cannot fully audit, and often receive too late to fix.
I support pharma insights teams as a Fractional Chief Methodologist, providing senior judgment across study design, vendor oversight, interpretation, and stakeholder communication. My role blends methodological rigor with business-oriented clarity, ensuring that insights are defensible, actionable, and aligned with internal expectations.
Pharma teams bring me in to strengthen vendor study designs, ensure defensibility, challenge assumptions, support junior analysts, and improve internal credibility — all without adding full-time headcount.
DEFENSIBILITY
CREDIBILITY
RISK REDUCTION
Advisory Access
Senior methodological review that improves vendor quality and internal confidence
Review of 1–2 vendor study designs per month
1–2 strategic calls for design, interpretation, or stakeholder prep
Asynchronous input on methodological decisions
Light review of toplines or vendor deliverables
Ideal for lean insights teams needing senior methodological support to challenge vendors and ensure defensibility
Tiered Support for Pharma Insights Teams
Embedded Oversight
A deeper partnership that improves vendor performance and elevates internal capability
Weekly touchpoints for vendor oversight, design review, or stakeholder prep
Review of 3–4 study designs per month
Light review of outputs and toplines
Mentoring for 1–2 junior analysts
Input on modeling choices, defensibility, and analytic interpretation
Ideal for teams managing multiple vendors or complex pipelines
Fractional Leadership
A part-time methodological leader who ensures defensibility across your entire research portfolio
Strategic planning and quarterly portfolio review
Oversight of all vendor study designs
Review of 6–10 study designs per month
Attend 1–2 strategic presentations per month (stakeholder-facing)
Targeted hands-on modeling for high-stakes or politically sensitive work
Ideal for insights teams needing a senior methodological voice in stakeholder conversations
Roll-Forward Policy
Unused capacity rolls forward for 30 days. Capacity refers to the study design reviews, strategic touchpoints, or senior oversight interactions included in your tier. This ensures you always receive the full value of your monthly engagement without shifting to an hourly model. Roll-forward capacity is capped at one month to maintain balance and ensure high-quality oversight